FOUNTAIN NATHAN B received a stock award from ACUMEN PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/5/2026ACC: 0001628280-26-041281
Director
Since Jun 2021
+88.75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
88.75K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+35.50K
Price / share
—
Trade value
—
% of position
186.4%
6/3/2026
19.05K→54.55K
Total
Net shares
+35.50K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/3/2026 | A · Award | +35.50K | — | — | 186.4% | 19.05K | 54.55K |
| Total | +35.50K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
53.25K shares
Shares
+53.25K
Strike price
2.29
Held after
53.25K
Exercisable
—
6/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock53.25K shares | 6/3/2026 | A · Award | +53.25K | 2.29 | — | 53.25K |